Compass Therapeutics, Inc. CMPX Q1 2025 earnings
Reported May 8, 2025 · Before market open
EPS-$0.12In line
EPS estimate-$0.12
Next report
Aug 10, 2026 (In 1 week)Revenue estimate-$600.0K
EPS estimate-$0.10
Versus estimates
Diluted EPS
Ask the moment Compass Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Compass Therapeutics, Inc. report Q1 2025 earnings?
- Compass Therapeutics, Inc. (CMPX) reported Q1 2025 earnings on May 8, 2025 before market open.
- What were Compass Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Compass Therapeutics, Inc. reported eps of $-0.12 for Q1 2025.
- Did Compass Therapeutics, Inc. beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.12 by $0.00.
- How did Compass Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 50.0% from $-0.08.
- Where can I find Compass Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001171843-25-002953) directly on SEC EDGAR. The filing index links above go to sec.gov.